NCT00212108
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- National University Hospital Singapore
Clinical trial condition
Nasopharyngeal Carcinoma
Explore clinical trials studying Nasopharyngeal Carcinoma. Study availability and eligibility vary by location and protocol.
237 public trials
79 recruiting studies
Nasopharyngeal Carcinoma trial results
NCT01449942
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- XiangYa Hospital, Central South University Changsha, Hunan, China
NCT00700440
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China
NCT00173836
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- X-ray fluoroscopy Taipei, Taiwan
Active, Not Recruiting
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05813626
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
Active, Not Recruiting
Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
NCT03097939
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- National Cancer Center Singapore Singapore
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
NCT04825990
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Asst Degli Spedali Civili Di Brescia Brescia, Italy
Active, Not Recruiting
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
NCT05211232
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- The Affiliated Hospital of Guangdong Medical College Zhanjiang, Guangdong, China
- Wuzhou Red Cross Hospital Wuzhou, Guangxi, China
- Guizhou Cancer Hospital Guiyang, Guizhou, China
- Hunan Cancer Hospital Changsha, Hunan, China
Active, Not Recruiting
Optimization of Cervical Nodal CTV for Early and Medium Stage NPC
NCT05145660
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, China